{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:15:38Z","timestamp":1791375338971,"version":"4.3.1"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijid.2025.108104","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:17:08Z","timestamp":1760001428000},"page":"108104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Experience of treatment with long-acting injectable cabotegravir\/rilpivirine (LA iCAB\/RPV) in viremic young patients with perinatally acquired HIV with adherence challenges: A five-case series"],"prefix":"10.1016","volume":"161","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5472-7032","authenticated-orcid":false,"given":"Cl\u00e9mentine","family":"de La Porte des Vaux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice-Andr\u00e9e","family":"Mariaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Viard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijid.2025.108104_bib0001","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/ije\/dyr164","article-title":"All-cause mortality in treated HIV-infected adults with CD4 \u2265500\/mm3 compared with the general population: evidence from a large European observational cohort collaboration","volume":"41","author":"Lewden","year":"2012","journal-title":"Int J Epidemiol"},{"issue":"5","key":"10.1016\/j.ijid.2025.108104_bib0002","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1016\/S2352-3018(23)00051-6","article-title":"Long-acting antiretrovirals and HIV treatment adherence","volume":"10","author":"Nachega","year":"2023","journal-title":"Lancet HIV"},{"issue":"1","key":"10.1016\/j.ijid.2025.108104_bib0003","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/COH.0000000000000904","article-title":"Use of long-acting injectable cabotegravir\/rilpivirine in people with HIV and adherence challenges","volume":"20","author":"Christopoulos","year":"2025","journal-title":"Curr Opin HIV AIDS"},{"issue":"1","key":"10.1016\/j.ijid.2025.108104_bib0004","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/cid\/ciad511","article-title":"Long-acting injectable cabotegravir\/rilpivirine effective in a small patient cohort with virologic failure on oral antiretroviral therapy","volume":"78","author":"Brock","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ijid.2025.108104_bib0005","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/cid\/ciae500","article-title":"Viral suppression rates at 48 weeks in people with HIV starting long-acting cabotegravir\/rilpivirine with initial viremia","volume":"80","author":"Hickey","year":"2025","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2025.108104_bib0006","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/hiv.12411","article-title":"Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe","volume":"18","author":"Judd","year":"2017","journal-title":"HIV Med"},{"key":"10.1016\/j.ijid.2025.108104_bib0007","article-title":"Immunovirological status in people with perinatal and adult-acquired HIV-1 infection: a multi-cohort analysis from France","volume":"40","author":"Seng","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"4","key":"10.1016\/j.ijid.2025.108104_bib0008","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/S2352-3018(23)00300-4","volume":"11","author":"Gaur","year":"2024","journal-title":"Lancet HIV"},{"issue":"7","key":"10.1016\/j.ijid.2025.108104_bib0009","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/INF.0000000000004742","article-title":"Efficacy, safety and retention in care among adolescents and youth with HIV on long-acting injectable cabotegravir\/rilpivirine treatment: real-world observational cohort outcomes","volume":"44","author":"Williams","year":"2025","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.ijid.2025.108104_bib0010","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1086\/653674","article-title":"Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF\/ANRS CO10)","volume":"51","author":"Dollfus","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2025.108104_bib0011","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/cid\/ciae016","article-title":"Virological failure after switch to long-acting cabotegravir and rilpivirine injectable therapy: an in-depth analysis","volume":"79","author":"van Welzen","year":"2024","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225003261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225003261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:05:17Z","timestamp":1780664717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225003261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":11,"alternative-id":["S1201971225003261"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108104","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experience of treatment with long-acting injectable cabotegravir\/rilpivirine (LA iCAB\/RPV) in viremic young patients with perinatally acquired HIV with adherence challenges: A five-case series","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108104"}}